D61.811 Other drug-induced pancytopenia

Name of the Condition

• Other drug-induced pancytopenia (ICD-10 Code D61.811)

Summary

This condition involves a reduction in all three major blood cell types—red blood cells, white blood cells, and platelets—caused by drug exposure. It can lead to anemia, increased infection risk, and bleeding tendencies, depending on the severity of cell deficiencies.

Causes

The primary cause is the toxic effect of specific medications on the bone marrow, impairing its ability to produce blood cells. This occurs when drugs interfere with normal hematopoiesis, either directly or through immune-mediated mechanisms.

Risk Factors

• Risk factors include the type and dosage of the causative drug, duration of exposure, pre-existing bone marrow conditions, and individual patient susceptibility. Polypharmacy or use of known marrow-suppressing agents may increase likelihood.

Symptoms

• Patients may experience fatigue, weakness, pale skin, shortness of breath, easy bruising or bleeding, frequent infections, and dizziness. Symptoms correlate with the degree of blood cell deficiencies.

Diagnosis

Diagnosis is confirmed through a complete blood count (CBC) showing low levels of red blood cells, white blood cells, and platelets. A bone marrow biopsy may be performed to assess marrow function and rule out other causes.

Treatment Options

• Treatment focuses on discontinuing the offending drug and managing symptoms. Options may include blood transfusions, growth factors to stimulate cell production, or supportive care to address complications like infections or bleeding.

Prognosis and Follow-Up

Prognosis depends on the reversibility of bone marrow damage and the ability to identify and avoid the causative drug. Follow-up includes monitoring blood counts to assess recovery and prevent recurrence.

Complications

• Potential complications include severe anemia, life-threatening infections, uncontrolled bleeding, and progression to chronic bone marrow failure if the underlying cause is not addressed.

Lifestyle & Prevention

• Avoid known marrow-suppressing drugs when possible. If treatment with such drugs is necessary, regular blood monitoring is recommended to detect early signs of pancytopenia.

When to Seek Professional Help

Seek immediate medical attention for symptoms like unexplained bruising, prolonged bleeding, high fever, or severe fatigue, as these may indicate serious blood cell deficiencies.

Tips for Medical Coders

Document the specific drug or class of drugs responsible for the pancytopenia, as this is critical for accurate coding. Ensure clinical correlation between drug exposure and the onset of symptoms to support the diagnosis.